Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Sep;82(3):456-67.
doi: 10.1093/jurban/jti091. Epub 2005 Jul 13.

Challenges in motivating treatment enrollment in community syringe exchange participants

Affiliations
Clinical Trial

Challenges in motivating treatment enrollment in community syringe exchange participants

Michael Kidorf et al. J Urban Health. 2005 Sep.

Abstract

Participants of syringe exchange programs (SEPs) exhibit high rates of substance use disorder but remain extremely ambivalent about seeking treatment. This study evaluated the effectiveness of motivational interviewing (MI) for encouraging SEP participants to enroll in substance abuse treatment. New opioid-dependent registrants to the Baltimore Needle Exchange Program (BNEP) (n =302) completed the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and the Addiction Severity Index (ASI) and were randomly assigned to one of three treatment referral conditions: (1) MI, (2) job readiness (JR) (attention control), or (3) standard referral. Participants in each condition who expressed interest in treatment were referred to a treatment readiness group that provided further encouragement and referral to programs that were accepting new admissions. Participants were observed for 1 year following the intervention. The results showed that 10.9% of study participants enrolled in substance abuse treatment, although no condition effects were observed. White participants and those diagnosed with major depression were most likely to enter treatment. The results suggest that a single motivational interview is insufficient to motivate changes in treatment seeking in this population, whereas the identification of predictors of treatment enrollment is worthy of further investigation.

PubMed Disclaimer

References

    1. Vlahov D, Jarlais DC, Goospby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154:S70–S77. doi: 10.1093/aje/154.12.S70. - DOI - PubMed
    1. Jarlais DC, Friedman SR, Casriel C. Target groups for preventing AIDS among intravenous drug users 2. The “hard” data studies. J Consult Clin Psychol. 1990;58:50–56. doi: 10.1037/0022-006X.58.1.50. - DOI - PubMed
    1. Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991. doi: 10.1016/S0140-6736(96)02536-6. - DOI - PubMed
    1. Kaplan EH, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr. 1994;7:182–189. - PubMed
    1. Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993;95:214–220. doi: 10.1016/0002-9343(93)90263-O. - DOI - PubMed

Publication types